Ikapharmindo Putramas Tbk. vs Bank China Construction Bank Indonesia Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Bank China Construction Bank Indonesia Tbk. trades at Rp68 (market cap 2.52T, 1.21M 24h volume). The key difference: Bank China Construction Bank Indonesia Tbk. is far larger — about 8.3× Ikapharmindo Putramas Tbk.'s market cap, and Bank China Construction Bank Indonesia Tbk. is more actively traded (1.21M versus 13.7K). Which is the better fit depends on your goals.
| IKPM | MCOR | |
|---|---|---|
Market Cap | 304.92B | 2.52T |
Volume | 13.7K | 1.21M |
Lot | 137 | 12.07K |
Turnover | 2.49M | 81.26M |
Average Price | 181.39 | 67.32 |
Value | 2.49M | 81.26M |
Indicative Equilibrium Price | — | 67 |
Indicative Equilibrium Volume | — | 1.8K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.
Read more on MCOR →